Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5935
pubmed:dateCreated
1975-1-22
pubmed:abstractText
Fifty-eight children with minimal-change nephrotic lesions who relapsed repeatedly and showed toxic side effects from corticosteroids were treated with cyclophosphamide for an average of 12 weeks. The initial dose was 5 mg/kg/day. Four to seven years (mean 5.8 years) later 20 remained in remission, 34 were still relapsing, and 4 had died (two during relapses, one of measles after cyclophosphamide, and one of a brain-stem astrocytoma). The half time for the relapse-free period after treatment was 2.8 years. There was no relationship between the length of treatment with cyclophosphamide and the stability of remission within the limits studied.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-14099134, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4110052, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4113070, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4113192, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4113514, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4115243, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4116965, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4117757, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4118670, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4123616, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4125201, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4129067, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4186456, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4193942, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4194935, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4321778, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4554082, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4574639, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4589814, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4698337, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4698338, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4754963, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4755436, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4855503, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-4933113, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-5578246, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-5774315, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-5782815, http://linkedlifedata.com/resource/pubmed/commentcorrection/4425844-5917978
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0007-1447
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7-11
pubmed:dateRevised
2010-10-26
pubmed:meshHeading
pubmed:year
1974
pubmed:articleTitle
Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
pubmed:publicationType
Journal Article